Cancer stem-like cells
Showing 1 - 25 of >10,000
Acute Myeloid Leukemia, Leukemia, Leukemia, Myeloid Trial in Boston (Cytokine Induced Memory-like Natural Killer Cells,
Not yet recruiting
- Acute Myeloid Leukemia
- +5 more
- Cytokine Induced Memory-like Natural Killer Cells
- Interleukin-2
-
Boston, Massachusetts
- +1 more
Nov 14, 2023
Ovarian Cancer Trial in Oklahoma City (Unesbulin)
Active, not recruiting
- Ovarian Cancer
-
Oklahoma City, OklahomaUniversity of Oklahoma Health Sciences Center
Feb 21, 2022
Organic Erectile Dysfunction Trial in Guangzhou (Very small embryonic-like stem cell(VSEL))
Withdrawn
- Organic Erectile Dysfunction
- Very small embryonic-like stem cell(VSEL)
-
Guangzhou, Guangdong, ChinaCentral laboratory in Fuda cancer hospital
Oct 13, 2020
Stem Cell Transplant Complications, Knee Osteoarthritis Trial in Guangzhou (very small embryonic-like stem cell)
Withdrawn
- Stem Cell Transplant Complications
- Knee Osteoarthritis
- very small embryonic-like stem cell
-
Guangzhou, Guangdong, ChinaBiological treatment center in Fuda cancer hospital
Oct 13, 2020
Stem Cell Transplant Complications, Skin Inflammation Trial in Guangzhou (Very small embryonic-like stem cell)
Withdrawn
- Stem Cell Transplant Complications
- Skin Inflammation
- Very small embryonic-like stem cell
-
Guangzhou, Guangdong, ChinaBiological treatment center in Fuda cancer hospital
Oct 13, 2020
Stem Cell Transplant Complications, Premature Ovarian Failure Trial in Guangzhou (very small embryonic-like stem cell)
Withdrawn
- Stem Cell Transplant Complications
- Premature Ovarian Failure
- very small embryonic-like stem cell
-
Guangzhou, Guangdong, ChinaBiological treatment center in Fuda cancer hospital
Oct 13, 2020
MDSCs and Cancer Stem Cells and Their Cross Talks in NSCLC
Not yet recruiting
- Lung Neoplasms
- +2 more
- Tumor samples
-
Bordeaux, FranceCHU de Bordeaux - Hôpital Saint-André, Service d'Oncologie Médic
Aug 28, 2023
Acute Myeloid Leukemia, Acute Myeloid Leukemia Recurrent, Leukemia Trial in Boston (Cytokine-Induced Memory-like Natural Killer
Not yet recruiting
- Acute Myeloid Leukemia
- +3 more
- Cytokine-Induced Memory-like Natural Killer Cells
- +2 more
-
Boston, Massachusetts
- +1 more
Nov 22, 2023
Cancer Stem Cell Specific Aptamer's Ability to Detect Blood
Completed
- Pancreatic Neoplasm
-
Seoul, Korea, Republic ofYonsei University Health System, Severance Hospital
Feb 15, 2023
Pancreatic Cancer, Ovarian Cancer, Adenocarcinoma Trial in Houston (TROP2-CAR-NK, Cyclophosphamide, Fludarabine)
Not yet recruiting
- Pancreatic Cancer
- +2 more
- TROP2-CAR-NK
- +2 more
-
Houston, TexasM D Anderson Cancer Center
Jun 27, 2023
Cerebral Adrenoleukodystrophy Trial in Minneapolis (Mesenchymal stem cells (IV-MSC))
Recruiting
- Cerebral Adrenoleukodystrophy
- Mesenchymal stem cells (IV-MSC)
-
Minneapolis, MinnesotaMasonic Cancer Center, University of Minnesota
Sep 7, 2023
Glioblastoma Trial in Rozzano (18F-GE-180 PET, Advanced MRI, Collection of hematopoietic stem cells)
Not yet recruiting
- Glioblastoma
- 18F-GE-180 PET
- +4 more
-
Rozzano, (mi), ItalyIRCCS Istituto Clinico Humanitas
Oct 27, 2023
Lymphoma Trial in Chongqing (PEG-rhG-CSF, RhG-CSF)
Recruiting
- Lymphoma
-
Chongqing, Chongqing, ChinaChongqing University Cancer Hospital
Aug 31, 2023
MACSSI (MAstectomie Cellules Souches Surveillance Immunitaire)
Recruiting
- Breast Cancer
- Characterization of breast stem & immune system cells infiltrated in the mammary gland
-
Lyon, FranceCentre Léon Bérard
Aug 26, 2022
Ovarian Cancer Trial in Chongqing (Autologous blood transfusion with haematopoietic stem cells)
Recruiting
- Ovarian Cancer
- Autologous blood transfusion with haematopoietic stem cells
-
Chongqing, Chongqing, ChinaChongqing University Cancer Hospital
May 29, 2022
iPSC Neurons From Adult Survivors of Childhood Cancer Who Have
Active, not recruiting
- Leukemia
- Lymphoma
-
Memphis, TennesseeSt. Jude Children's Research Hospital
May 16, 2022
Glioblastoma, Glioblastoma Multiforme, Glioma Trial in Los Angeles (Dendritic cell vaccination, in addition to standard
Completed
- Glioblastoma
- +4 more
- Dendritic cell vaccination, in addition to standard temozolomide chemotherapy and involved field radiation therapy
- Dendritic cell vaccination, with optional bevacizumab treatment for patients previously treated with bevacizumab
-
Los Angeles, CaliforniaCedars-Sinai Medical Center
Nov 18, 2021
B Acute Lymphoblastic Leukemia With t(v;11q23.3); KMT2A Rearranged, Recurrent B Acute Lymphoblastic Leukemia, Recurrent Chronic
Terminated
- B Acute Lymphoblastic Leukemia With t(v;11q23.3); KMT2A Rearranged
- +16 more
- Autologous CD19-CD8-CD28-CD3zeta-CAR-mbIL15-HER1t T Cells
- +2 more
-
Houston, TexasM D Anderson Cancer Center
May 28, 2021
Cervical Cancer Trial in Chongqing (Autologous blood transfusion with haematopoietic stem cells)
Recruiting
- Cervical Cancer
- Autologous blood transfusion with haematopoietic stem cells
-
Chongqing, Chongqing, ChinaChongqing University Cancer Hospital
Sep 13, 2022
Multiple Myeloma Trial in Boston (CIML NK Cells plus KP1237 and low dose IL-2)
Recruiting
- Multiple Myeloma
- CIML NK Cells plus KP1237 and low dose IL-2
-
Boston, MassachusettsDana Farber Cancer Institute
Jan 18, 2022
Accelerated Phase Chronic Myelogenous Leukemia, BCR-ABL1 Positive, Acute Erythroid Leukemia, Acute Megakaryoblastic Leukemia
Completed
- Accelerated Phase Chronic Myelogenous Leukemia, BCR-ABL1 Positive
- +14 more
- Aldesleukin
- +7 more
-
Houston, TexasM D Anderson Cancer Center
Jul 31, 2022
Cancer of Breast Trial in San Antonio (Rapamycin)
Active, not recruiting
- Cancer of Breast
-
San Antonio, TexasUniversity of Texas Health Science Center San Antonio
Mar 6, 2022
Multiple Myeloma Trial in New York (drug, biological, procedure)
Active, not recruiting
- Multiple Myeloma
- busulfan
- +4 more
-
New York, New YorkMemorial Sloan Kettering Cancer Center
Jan 3, 2023
Plasma Cell Leukemia, Plasma Cell Myeloma Trial in Houston (procedure, biological, other, drug)
Active, not recruiting
- Plasma Cell Leukemia
- Plasma Cell Myeloma
- Autologous Hematopoietic Stem Cell Transplantation
- +6 more
-
Houston, TexasM D Anderson Cancer Center
Aug 18, 2022
Pancreatic Adenocarcinoma Metastatic, BRCA1 Mutation, BRCA2 Mutation Trial in Boston, New York (Melphalan, BCNU, Vitamin B12B)
Recruiting
- Pancreatic Adenocarcinoma Metastatic
- +14 more
- Melphalan
- +5 more
-
Boston, Massachusetts
- +1 more
Dec 6, 2022